Lisata Therapeutics (LSTA) Current Deferred Revenue (2010 - 2017)
Lisata Therapeutics (LSTA) reported Current Deferred Revenue of $5.36 million for Q1 2017, down 4.9% from $5.64 million a year earlier but up 5.2% from the prior quarter.
Powered by 
Analysis
Lisata Therapeutics (LSTA) Current Deferred Revenue (2010 - 2017) Analysis & Trends
At the end of FY2016, Lisata Therapeutics posted Current Deferred Revenue of $5.1 million, down 4.6% from FY2015.
- Current Deferred Revenue has a five-year compound annual growth rate of 35.4% (FY2011 to FY2016).
- By year, Current Deferred Revenue came in at $5.35 million in FY2015 (+23.3%), $4.33 million in FY2014 (+138.6%), $1.82 million in FY2013 (+23.7%) and $1.47 million in FY2012 (+31.0%).
- Five-year quarterly Current Deferred Revenue spans a low of $362,041 in Q2 2013 and a high of $7.23 million in Q2 2016.
- Year over year, Current Deferred Revenue gained in six of the last eight quarters, with growth averaging 24.2%.
- The high point for year-over-year Current Deferred Revenue in five years was Q2 2014 (growth of 681.8%); the low point was Q2 2013 (a decline of 77.8%).
- Per Business Quant data, the three quarters before Q1 2017 came in at $5.1 million (Q4 2016), $5.87 million (Q3 2016) and $7.23 million (Q2 2016).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Lisata Therapeutics | 13.40 Mn | 13.15 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2017 | 5.36 Mn |
| Dec 31, 2016 | 5.10 Mn |
| Sep 30, 2016 | 5.87 Mn |
| Jun 30, 2016 | 7.23 Mn |
| Mar 31, 2016 | 5.64 Mn |
| Dec 31, 2015 | 5.35 Mn |
| Sep 30, 2015 | 5.50 Mn |
| Jun 30, 2015 | 4.64 Mn |
| Mar 31, 2015 | 5.51 Mn |
| Dec 31, 2014 | 4.33 Mn |
| Sep 30, 2014 | 3.64 Mn |
| Jun 30, 2014 | 2.83 Mn |
| Mar 31, 2014 | 2.03 Mn |
| Dec 31, 2013 | 1.82 Mn |
| Sep 30, 2013 | 1.02 Mn |
| Jun 30, 2013 | 362,041.00 |
| Mar 31, 2013 | 1.82 Mn |
| Dec 31, 2012 | 1.47 Mn |
| Sep 30, 2012 | 778,088.00 |
| Jun 30, 2012 | 1.63 Mn |
API Access
Lisata Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=LSTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "LSTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=LSTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();